Experienced financial professional with demonstrated strong financial acumen and leadership skills across various roles within the pharmaceutical and medical device industry.As a Finance Director within Johnson & Johnson's DePuy Synthes division, I am currently responsible for analyzing inventory risks and making recommendations to minimize them. I have successfully implemented valuation analysis for capital and inventory spending, which has significantly improved decision-making processes. Additionally, I took the initiative to restructure the E&O policy to better align it with policy and lifecycle management.In my previous role as a Finance Director within J&J, I provided strategic financial support for the Global Joints Platform and newly created Digital Franchise. It was an exciting opportunity for me to oversee the innovation pipeline and manage budgets for marketing and R&D. I played a key role in turning around the Knee franchise and achieving operational growth, as well as maintaining share of the Hip franchise. This involved leading project prioritization, conducting forecast analyses, and providing launch support for the VELYS Robotically Assisted Surgery Devices for Knees Prior to that, I served as a Senior Finance Manager for Insulin Delivery. This role allowed me to drive financial and valuation scenarios that were crucial in the successful winding down of the Animas business and transitioning patients to Medtronic. I also handled complex accounting tasks, supported due diligence efforts, and analyzed commercial programs. It was a challenging but rewarding experience, and I am proud of my contributions.Before that, I was a Finance Manager for US OTC Allergy/Eye and Marketing & Advertising Expenses. This position provided me with the opportunity to take on the role of franchise leader for several well-known brands. I successfully drove significant results and made a positive impact on brand performance.